NEWS | RESEARCH
Bone Graft Manufacturer Advances Randomized Trials in Spinal and Ankle Fusion .
Clinical evidence generation for synthetic bone graft substitutes continues to expand. Kuros Biosciences reported progress across 3 prospective trials evaluating its MagnetOs bone graft technology, with enrollment reaching 97% in PROOF, 55% in PRECISE and 18% in ASTRA. The studies investigate fusion applications in the spine and hindfoot or ankle. The company also reported 40% year-over-year medical device sales growth and expanded US manufacturing. These developments indicate growing clinical and commercial activity, although definitive comparative trial results are still pending.
Read the full News article from Ortho Spine News
Read Article
DISCLAIMER
Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.
